Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,095 | -7,986 | -2,683 | -15,217 | N/A |
| Depreciation Amortization | 1,152 | 752 | 378 | 1,518 | N/A |
| Accounts receivable | -1,498 | -393 | -307 | -1,034 | N/A |
| Other Working Capital | -2,647 | -3,405 | -1,822 | -3,677 | N/A |
| Other Operating Activity | 3,961 | 2,206 | -2,746 | 3,315 | 0 |
| Operating Cash Flow | $-13,127 | $-8,826 | $-7,180 | $-15,095 | $N/A |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | N/A | N/A | -189 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -188 | 0 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-188 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -9,293 | -9,293 | -9,293 | -1,009 | N/A |
| Common Stock Issued | 96,553 | 48,453 | 47,349 | 8,713 | N/A |
| Other Financing Activity | -6,796 | -3,419 | -3,277 | -1,061 | 0 |
| Financing Cash Flow | $80,464 | $35,741 | $34,779 | $6,643 | $N/A |
| Exchange Rate Effect | 630 | -649 | 1,233 | N/A | N/A |
| Beginning Cash Position | 14,800 | 14,800 | 14,800 | 23,126 | N/A |
| End Cash Position | 82,767 | 41,066 | 43,632 | 14,486 | N/A |
| Net Cash Flow | $67,967 | $26,266 | $28,832 | $-8,640 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,127 | -8,826 | -7,180 | -15,095 | N/A |
| Free Cash Flow | -13,127 | -8,826 | -7,180 | -15,095 | 0 |